Jonathan T Elliott1, Kimberley S Samkoe2, Jason R Gunn3, Errol E Stewart4, Timothy B Gardner5, Kenneth M Tichauer6, Ting-Yim Lee4, P Jack Hoopes2, Stephen P Pereira7, Tayyaba Hasan8, Brian W Pogue2. 1. Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755-8000. Electronic address: Jonathan.T.Elliott@dartmouth.edu. 2. Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755-8000; Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire. 3. Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755-8000. 4. Department of Medical Biophysics, Western University, London, Ontario, Canada. 5. Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire. 6. Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois. 7. Institute for Liver and Digestive Health, University College London, London, United Kingdom. 8. Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts.
Abstract
RATIONALE AND OBJECTIVES: It was hypothesized that perfusion computed tomography (CT), blood flow (BF), blood volume (BV), and vascular permeability surface area (PS) product parameters would be predictive of therapeutic anticancer agent uptake in pancreatic cancer, facilitating image-guided interpretation of human treatments. The hypothesis was tested in an orthotopic rabbit model of pancreatic cancer, by establishing the model, imaging with endoscopic ultrasound (EUS) and contrast CT, and spatially comparing the perfusion maps to the ex vivo uptake values of the injected photosensitizer, verteporfin. MATERIALS AND METHODS: Nine New Zealand white rabbits underwent direct pancreas implantation of VX2 tumors, and CT perfusion or EUS was performed 10 days postimplantation. Verteporfin was injected during CT imaging, and the tissue was removed 1 hour postinjection for frozen tissue fluorescence scanning. Region-of-interest comparisons of CT data with ex vivo fluorescence and histopathologic staining were performed. RESULTS: Dynamic contrast-enhanced CT showed enhanced BF, BV, and PS in the tumor rim and decreased BF, BV, and PS in the tumor core. Significant correlations were found between ex vivo verteporfin concentration and each of BF, BV, and PS. CONCLUSIONS: The efficacy of verteporfin delivery in tumors is estimated by perfusion CT, providing a noninvasive method of mapping photosensitizer dose.
RATIONALE AND OBJECTIVES: It was hypothesized that perfusion computed tomography (CT), blood flow (BF), blood volume (BV), and vascular permeability surface area (PS) product parameters would be predictive of therapeutic anticancer agent uptake in pancreatic cancer, facilitating image-guided interpretation of human treatments. The hypothesis was tested in an orthotopic rabbit model of pancreatic cancer, by establishing the model, imaging with endoscopic ultrasound (EUS) and contrast CT, and spatially comparing the perfusion maps to the ex vivo uptake values of the injected photosensitizer, verteporfin. MATERIALS AND METHODS: Nine New Zealand white rabbits underwent direct pancreas implantation of VX2 tumors, and CT perfusion or EUS was performed 10 days postimplantation. Verteporfin was injected during CT imaging, and the tissue was removed 1 hour postinjection for frozen tissue fluorescence scanning. Region-of-interest comparisons of CT data with ex vivo fluorescence and histopathologic staining were performed. RESULTS: Dynamic contrast-enhanced CT showed enhanced BF, BV, and PS in the tumor rim and decreased BF, BV, and PS in the tumor core. Significant correlations were found between ex vivo verteporfin concentration and each of BF, BV, and PS. CONCLUSIONS: The efficacy of verteporfin delivery in tumors is estimated by perfusion CT, providing a noninvasive method of mapping photosensitizer dose.
Authors: Kimberley S Samkoe; Amber Bryant; Jason R Gunn; Stephen P Pereira; Tayyaba Hasan; Brian W Pogue Journal: J Biomed Opt Date: 2013-12 Impact factor: 3.170
Authors: Ron C Gaba; Brian Jin; Dingxin Wang; Robert J Lewandowski; Ann B Ragin; Andrew C Larson; Riad Salem; Reed A Omary Journal: AJR Am J Roentgenol Date: 2012-05 Impact factor: 3.959
Authors: Jennifer Pascal; Elaine L Bearer; Zhihui Wang; Eugene J Koay; Steven A Curley; Vittorio Cristini Journal: Proc Natl Acad Sci U S A Date: 2013-08-12 Impact factor: 11.205
Authors: M T Huggett; M Jermyn; A Gillams; R Illing; S Mosse; M Novelli; E Kent; S G Bown; T Hasan; B W Pogue; S P Pereira Journal: Br J Cancer Date: 2014-02-25 Impact factor: 7.640
Authors: Gal Shafirstein; Emily Oakley; Sasheen Hamilton; Michael Habitzruther; Sarah Chamberlain; Sandra Sexton; Leslie Curtin; David A Bellnier Journal: Methods Mol Biol Date: 2022